Exact Mass: 571.1972834000001
Exact Mass Matches: 571.1972834000001
Found 268 metabolites which its exact mass value is equals to given mass value 571.1972834000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyclochlorotine
Islanditoxin
Islanditoxin is a mycotoxin produced by the common food storage mould Penicillium islandicu
Cyclochlorotine
Cyclochlorotine is a mycotoxin produced by the common food storage mould Penicillium islandicu
Telaglenastat
C471 - Enzyme Inhibitor Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity[1].
(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]azetidin-2-one
Umbralisib
C31H24F3N5O3 (571.1831149999999)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Scutebarbatine E
A diterpene alkaloid of group of neo-clerodanes isolated from the whole plants of Scutellaria barbata and has been shown to exhibit neoplastic activity.
Phe Tyr Asn Glu
Asn Tyr Phe Glu
Cys Met Arg Tyr
Cys Met Tyr Arg
Cys Arg Met Tyr
Cys Arg Tyr Met
Cys Thr Trp Tyr
C27H33N5O7S (571.2100588000001)
Cys Thr Tyr Trp
C27H33N5O7S (571.2100588000001)
Cys Trp Thr Tyr
C27H33N5O7S (571.2100588000001)
Cys Trp Tyr Thr
C27H33N5O7S (571.2100588000001)
Cys Tyr Met Arg
Cys Tyr Arg Met
Cys Tyr Thr Trp
C27H33N5O7S (571.2100588000001)
Cys Tyr Trp Thr
C27H33N5O7S (571.2100588000001)
Asp Asp His Trp
Asp Asp Trp His
Asp Phe Gln Tyr
Asp Phe Tyr Gln
Asp His Asp Trp
Asp His Trp Asp
Asp Gln Phe Tyr
Asp Gln Tyr Phe
Asp Trp Asp His
Asp Trp His Asp
Asp Tyr Phe Gln
Asp Tyr Gln Phe
Glu Phe Asn Tyr
Glu Phe Tyr Asn
Glu His Thr Trp
C26H33N7O8 (571.2390498000001)
Glu His Trp Thr
C26H33N7O8 (571.2390498000001)
Glu Asn Phe Tyr
Glu Asn Tyr Phe
Glu Thr His Trp
C26H33N7O8 (571.2390498000001)
Glu Thr Trp His
C26H33N7O8 (571.2390498000001)
Glu Trp His Thr
C26H33N7O8 (571.2390498000001)
Glu Trp Thr His
C26H33N7O8 (571.2390498000001)
Glu Tyr Phe Asn
Glu Tyr Asn Phe
Phe Asp Gln Tyr
Phe Asp Tyr Gln
Phe Glu Asn Tyr
Phe Glu Tyr Asn
Phe Phe Met Gln
Phe Phe Gln Met
Phe Gly Trp Tyr
Phe Gly Tyr Trp
Phe Met Phe Gln
Phe Met Gln Phe
Phe Asn Glu Tyr
Phe Asn Tyr Glu
Phe Gln Asp Tyr
Phe Gln Phe Met
Phe Gln Met Phe
Phe Gln Tyr Asp
Phe Trp Gly Tyr
Phe Trp Tyr Gly
Phe Tyr Asp Gln
Phe Tyr Glu Asn
Phe Tyr Gly Trp
Phe Tyr Gln Asp
Phe Tyr Trp Gly
Gly Phe Trp Tyr
Gly Phe Tyr Trp
Gly Trp Phe Tyr
Gly Trp Tyr Phe
Gly Tyr Phe Trp
Gly Tyr Trp Phe
His Asp Asp Trp
His Asp Trp Asp
His Glu Thr Trp
C26H33N7O8 (571.2390498000001)
His Glu Trp Thr
C26H33N7O8 (571.2390498000001)
His Thr Glu Trp
C26H33N7O8 (571.2390498000001)
His Thr Trp Glu
C26H33N7O8 (571.2390498000001)
His Trp Asp Asp
His Trp Glu Thr
C26H33N7O8 (571.2390498000001)
His Trp Thr Glu
C26H33N7O8 (571.2390498000001)
Met Cys Arg Tyr
Met Cys Tyr Arg
Met Phe Phe Gln
Met Phe Gln Phe
Met Met Gln Tyr
C24H37N5O7S2 (571.2134292000001)
Met Met Tyr Gln
C24H37N5O7S2 (571.2134292000001)
Met Gln Phe Phe
Met Gln Met Tyr
C24H37N5O7S2 (571.2134292000001)
Met Gln Tyr Met
C24H37N5O7S2 (571.2134292000001)
Met Arg Cys Tyr
Met Arg Tyr Cys
Met Tyr Cys Arg
Met Tyr Met Gln
C24H37N5O7S2 (571.2134292000001)
Met Tyr Gln Met
C24H37N5O7S2 (571.2134292000001)
Met Tyr Arg Cys
Asn Glu Phe Tyr
Asn Glu Tyr Phe
Asn Phe Glu Tyr
Asn Phe Tyr Glu
Asn Tyr Glu Phe
Gln Asp Phe Tyr
Gln Asp Tyr Phe
Gln Phe Asp Tyr
Gln Phe Phe Met
Gln Phe Met Phe
Gln Phe Tyr Asp
Gln Met Phe Phe
Gln Met Met Tyr
C24H37N5O7S2 (571.2134292000001)
Gln Met Tyr Met
C24H37N5O7S2 (571.2134292000001)
Gln Tyr Asp Phe
Gln Tyr Phe Asp
Gln Tyr Met Met
C24H37N5O7S2 (571.2134292000001)
Arg Cys Met Tyr
Arg Cys Tyr Met
Arg Met Cys Tyr
Arg Met Tyr Cys
Arg Tyr Cys Met
Arg Tyr Met Cys
Thr Cys Trp Tyr
C27H33N5O7S (571.2100588000001)
Thr Cys Tyr Trp
C27H33N5O7S (571.2100588000001)
Thr Glu His Trp
C26H33N7O8 (571.2390498000001)
Thr Glu Trp His
C26H33N7O8 (571.2390498000001)
Thr His Glu Trp
C26H33N7O8 (571.2390498000001)
Thr His Trp Glu
C26H33N7O8 (571.2390498000001)
Thr Trp Cys Tyr
C27H33N5O7S (571.2100588000001)
Thr Trp Glu His
C26H33N7O8 (571.2390498000001)
Thr Trp His Glu
C26H33N7O8 (571.2390498000001)
Thr Trp Tyr Cys
C27H33N5O7S (571.2100588000001)
Thr Tyr Cys Trp
C27H33N5O7S (571.2100588000001)
Thr Tyr Trp Cys
C27H33N5O7S (571.2100588000001)
Trp Cys Thr Tyr
C27H33N5O7S (571.2100588000001)
Trp Cys Tyr Thr
C27H33N5O7S (571.2100588000001)
Trp Asp Asp His
Trp Asp His Asp
Trp Glu His Thr
C26H33N7O8 (571.2390498000001)
Trp Glu Thr His
C26H33N7O8 (571.2390498000001)
Trp Phe Gly Tyr
Trp Phe Tyr Gly
Trp Gly Phe Tyr
Trp Gly Tyr Phe
Trp His Asp Asp
Trp His Glu Thr
C26H33N7O8 (571.2390498000001)
Trp His Thr Glu
C26H33N7O8 (571.2390498000001)
Trp Thr Cys Tyr
C27H33N5O7S (571.2100588000001)
Trp Thr Glu His
C26H33N7O8 (571.2390498000001)
Trp Thr His Glu
C26H33N7O8 (571.2390498000001)
Trp Thr Tyr Cys
C27H33N5O7S (571.2100588000001)
Trp Tyr Cys Thr
C27H33N5O7S (571.2100588000001)
Trp Tyr Phe Gly
Trp Tyr Gly Phe
Trp Tyr Thr Cys
C27H33N5O7S (571.2100588000001)
Tyr Cys Met Arg
Tyr Cys Arg Met
Tyr Cys Thr Trp
C27H33N5O7S (571.2100588000001)
Tyr Cys Trp Thr
C27H33N5O7S (571.2100588000001)
Tyr Asp Phe Gln
Tyr Asp Gln Phe
Tyr Glu Phe Asn
Tyr Glu Asn Phe
Tyr Phe Asp Gln
Tyr Phe Glu Asn
Tyr Phe Gly Trp
Tyr Phe Asn Glu
Tyr Phe Gln Asp
Tyr Phe Trp Gly
Tyr Gly Phe Trp
Tyr Gly Trp Phe
Tyr Met Cys Arg
Tyr Met Met Gln
C24H37N5O7S2 (571.2134292000001)
Tyr Met Gln Met
C24H37N5O7S2 (571.2134292000001)
Tyr Met Arg Cys
Tyr Asn Glu Phe
Tyr Asn Phe Glu
Tyr Gln Asp Phe
Tyr Gln Phe Asp
Tyr Gln Met Met
C24H37N5O7S2 (571.2134292000001)
Tyr Arg Met Cys
Tyr Thr Cys Trp
C27H33N5O7S (571.2100588000001)
Tyr Thr Trp Cys
C27H33N5O7S (571.2100588000001)
Tyr Trp Cys Thr
C27H33N5O7S (571.2100588000001)
Tyr Trp Phe Gly
Tyr Trp Gly Phe
Tyr Trp Thr Cys
C27H33N5O7S (571.2100588000001)
Islanditoxin
Benzamide, N-[1-[(2R)-3,5-di-O-benzoyl-2-deoxy-2-fluoro-2-methyl-α-D-erythro-pentofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]
(Z)-2-(2-Tritylaminothiazol-4-yl)-2-(2-tert-butoxycarbonylprop-2-oxyimino)acetic acid
(2R)-N-Benzoyl-2-deoxy-2-fluoro-2-methylcytidine 3,5-dibenzoate
5-O-DMT-N4-Ac-dC
C32H33N3O7 (571.2318388000001)
5'-O-DMT-N4-Ac-dC (N4-Acetyl-2'-deoxy-5'-O-DMT-cytidine, compound 7), a deoxynucleoside, can be used to synthesize of dodecyl phosphoramidite which is the raw material for dod‐DNA (amphiphilic DNA containing an internal hydrophobic region consisting of dodecyl phosphotriester linkages) synthesis[1][2].
Perazine Dimaleate
C28H33N3O8S (571.1988258000001)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
4-[3-Carboxymethyl-3-(4-phosphonooxy-benzyl)-ureido]-4-[(3-cyclohexyl-propyl)-methyl-carbamoyl]butyric acid
Umbralisib
C31H24F3N5O3 (571.1831149999999)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Telaglenastat
C471 - Enzyme Inhibitor Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity[1].
(2-O-methyl-beta-D-glucosyl)-(1->4)-(beta-D-glucosyl)-O-mycofactocinone
C26H37NO13 (571.2264792000001)
(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]azetidin-2-one
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C32H33N3O7 (571.2318388000001)
N-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
C29H37N3O7S (571.2352092000001)
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
3-(1,3-benzodioxol-5-yl)-1-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H37N3O7S (571.2352092000001)
3-(1,3-benzodioxol-5-yl)-1-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H37N3O7S (571.2352092000001)
3-(1,3-benzodioxol-5-yl)-1-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H37N3O7S (571.2352092000001)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C32H33N3O7 (571.2318388000001)
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C32H33N3O7 (571.2318388000001)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
3-(1,3-benzodioxol-5-yl)-1-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H37N3O7S (571.2352092000001)
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C32H33N3O7 (571.2318388000001)
N-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
C29H37N3O7S (571.2352092000001)
N-[[(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
C29H37N3O7S (571.2352092000001)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-4-phenoxybenzenesulfonamide
N-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
C29H37N3O7S (571.2352092000001)
N-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
C29H37N3O7S (571.2352092000001)
3-(1,3-benzodioxol-5-yl)-1-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H37N3O7S (571.2352092000001)
3-(1,3-benzodioxol-5-yl)-1-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H37N3O7S (571.2352092000001)
3-(1,3-benzodioxol-5-yl)-1-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H37N3O7S (571.2352092000001)
3-(1,3-benzodioxol-5-yl)-1-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C29H37N3O7S (571.2352092000001)
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C32H33N3O7 (571.2318388000001)
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C32H33N3O7 (571.2318388000001)
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C32H33N3O7 (571.2318388000001)
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C32H33N3O7 (571.2318388000001)
N-[[(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
C29H37N3O7S (571.2352092000001)
N-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
C29H37N3O7S (571.2352092000001)
N-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
C29H37N3O7S (571.2352092000001)
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
(3S,7R,9S,13S,16R)-17,18-dichloro-13-ethyl-3,9-bis(hydroxymethyl)-7-phenyl-1,4,8,11,14-pentazabicyclo[14.3.0]nonadecane-2,5,10,12,15-pentone
4-O-methylrhodomycin D
An anthracycline that is aklavinone having a 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl residue and a methyl group attached as positions 4 and 7 respectively.
17,18-Dichloro-9-ethyl-3,6-bis(hydroxymethyl)-13-phenyl-1,4,7,10,14-pentazabicyclo[14.3.0]nonadecane-2,5,8,11,15-pentone
(1s,3s,5r,6s)-8-methyl-6-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate
1,5-dimethyl (2s)-2-[(6as)-5-chloro-6a-methyl-9-(2-methylbut-2-enoyl)-3-[(1e,3s)-3-methylpent-1-en-1-yl]-6,8-dioxofuro[2,3-h]isoquinolin-2-yl]pentanedioate
C30H34ClNO8 (571.1972834000001)